Cargando…

Dopaminergic precursors differentiated from human blood-derived induced neural stem cells improve symptoms of a mouse Parkinson's disease model

Autologous neural stem cells (NSCs) may offer a promising source for deriving dopaminergic (DA) cells for treatment of Parkinson's disease (PD). Methods: By using Sendai virus, human peripheral blood mononuclear cells (PBMNCs) were reprogrammed to induced NSCs (iNSCs), which were then different...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Yanpeng, Tang, Xihe, Bai, Yun-Fei, Wang, Shuyan, An, Jing, Wu, Yanchuan, Xu, Zhi-Qing David, Zhang, Y. Alex, Chen, Zhiguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160767/ https://www.ncbi.nlm.nih.gov/pubmed/30279731 http://dx.doi.org/10.7150/thno.26643

Ejemplares similares

Evaluating the mouse neural precursor line, SN4741, as a suitable proxy for midbrain dopaminergic neurons
por: Boyd, Rachel J., et al.
Publicado: (2023)

Evaluating the mouse neural precursor line, SN4741, as a suitable proxy for midbrain dopaminergic neurons
por: Boyd, Rachel J., et al.
Publicado: (2023)

Evaluating the mouse neural precursor line, SN4741, as a suitable proxy for midbrain dopaminergic neurons
por: Boyd, Rachel J., et al.
Publicado: (2023)

Neuronal precursor cells with dopaminergic commitment in the rostral migratory stream of the mouse
por: Schweyer, Kerstin, et al.
Publicado: (2019)

Influence of Depressive Symptoms on Dopaminergic Treatment of Parkinson’s Disease
por: Hanganu, Alexandru, et al.
Publicado: (2014)

Selective Generation of Dopaminergic Precursors from Mouse Fibroblasts by Direct Lineage Conversion
por: Tian, Changhai, et al.
Publicado: (2015)

Co-Transplantation of GDNF-Overexpressing Neural Stem Cells and Fetal Dopaminergic Neurons Mitigates Motor Symptoms in a Rat Model of Parkinson’s Disease
por: Deng, Xingli, et al.
Publicado: (2013)

Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
por: Qamar, MA, et al.
Publicado: (2017)

FGF8 is Essential for Functionality of Induced Neural Precursor Cell-derived Dopaminergic Neurons
por: Lim, Mi-Sun, et al.
Publicado: (2015)

Acupuncture for Parkinson's Disease: Efficacy Evaluation and Mechanisms in the Dopaminergic Neural Circuit
por: Zhao, Yadan, et al.
Publicado: (2021)

Distinct Role of Striatal Functional Connectivity and Dopaminergic Loss in Parkinson’s Symptoms
por: Dukart, Juergen, et al.
Publicado: (2017)

Dissociable effects of dopaminergic medications on depression symptom dimensions in Parkinson’s disease
por: Costello, Harry, et al.
Publicado: (2023)

Shared functional neural substrates in Parkinson's disease and drug-induced parkinsonism: association with dopaminergic depletion
por: Oh, Se Won, et al.
Publicado: (2020)

Ferulic Acid Induces NURR1 Expression and Promotes Dopaminergic Differentiation in Neural Precursor Cells
por: Sadeghi-Zadeh, Maryam, et al.
Publicado: (2022)

Functional Integration of Grafted Neural Stem Cell-Derived Dopaminergic Neurons Monitored by Optogenetics in an In Vitro Parkinson Model
por: Tønnesen, Jan, et al.
Publicado: (2011)

Zhichan decoction induces differentiation of dopaminergic neurons in Parkinson's disease rats after neural stem cell transplantation
por: Shi, Huifen, et al.
Publicado: (2014)

Author Correction: Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
por: Qamar, M. A., et al.
Publicado: (2023)

Brain-specific NRSF deficiency aggravates dopaminergic neurodegeneration and impairs neurogenesis in the MPTP mouse model of Parkinson’s disease
por: Huang, Dongping, et al.
Publicado: (2019)

The immunogenicity of midbrain dopaminergic neurons and the implications for neural grafting trials in Parkinson’s disease
por: Qarin, Shamma, et al.
Publicado: (2021)

Dopaminergic regeneration by neurturin-overexpressing c17.2 neural stem cells in a rat model of Parkinson's disease
por: Liu, Wei-Guo, et al.
Publicado: (2007)

Clinical implications for dopaminergic and functional neuroimage research in cognitive symptoms of Parkinson’s disease
por: Hirano, Shigeki
Publicado: (2021)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson’s disease mouse model
por: Lv, Yi-Qing, et al.
Publicado: (2022)

CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease
por: Bengoa-Vergniory, Nora, et al.
Publicado: (2020)

Recent advances in dopaminergic strategies for the treatment of Parkinson’s disease
por: Mao, Qi, et al.
Publicado: (2020)

Retraction: Dopaminergic regeneration by neurturin-overexpressing c17.2 neural stem cells in a rat model of Parkinson's disease
por: Liu, Wei-Guo, et al.
Publicado: (2009)

Diverse midbrain dopaminergic neuron subtypes and implications for complex clinical symptoms of Parkinson’s disease
por: Carmichael, Kathleen, et al.
Publicado: (2021)

Beyond the Dopaminergic System: Lessons Learned from levodopa Resistant Symptoms in Parkinson's Disease
por: Antonini, Angelo, et al.
Publicado: (2023)

An Automated Cell Detection Method for TH-positive Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease Using Convolutional Neural Networks
por: Kim, Doyun, et al.
Publicado: (2023)

The impact of dopaminergic treatment over cognitive networks in Parkinson's disease: Stemming the tide?
por: Aracil‐Bolaños, Ignacio, et al.
Publicado: (2021)

Autologous iPSC-derived dopamine neuron transplantation in a nonhuman primate Parkinson’s disease model
por: Wang, Shuyan, et al.
Publicado: (2015)

Dopaminergic Neurons from Midbrain-Specified Human Embryonic Stem Cell-Derived Neural Stem Cells Engrafted in a Monkey Model of Parkinson’s Disease
por: Daadi, Marcel M., et al.
Publicado: (2012)

Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
por: Mamelak, Mortimer
Publicado: (2018)

Progranulin Gene Delivery Protects Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease
por: Van Kampen, Jackalina M., et al.
Publicado: (2014)

Clinical characteristics of fatigued Parkinson’s patients and the response to dopaminergic treatment
por: Fu, Rao, et al.
Publicado: (2016)

A survey into the influence of dopaminergic drug exposure on ‘sense of presence’ symptoms in patients with parkinson's disease
por: Padfield, Emma, et al.
Publicado: (2021)

Mean Diffusivity in the Dopaminergic System and Neural Differences Related to Dopaminergic System
por: Takeuchi, Hikaru, et al.
Publicado: (2018)

Region and dynamic specificities of adult neural stem cells and oligodendrocyte precursors in myelin regeneration in the mouse brain
por: Brousse, Béatrice, et al.
Publicado: (2016)

Region and dynamic specificities of adult neural stem cells and oligodendrocyte precursors in myelin regeneration in the mouse brain
por: Brousse, Béatrice, et al.
Publicado: (2015)

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease
por: Redenšek, Sara, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jh1n5aecunnfjfp1j4pi7jm7v0